Sachem Capital Corp. 8.00% Note
AMEX:SCCGREIT - Mortgage
+$0.14 today
- Market cap
- $1.18B
- Beta
- 0.40
- P/E (TTM)
- 1089.1
- EPS (TTM)
- $0.02
- Dividend yield
- 8.10%
Volume 0.00M
Average 0.00M
SCCG Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Sachem Capital Corp. 8.00% NoteAMEX: SCCG
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How SCCG compares with its peers on the latest reported figures
- SCCG's LTM Mar 2026 research & development of $0 is the 3rd highest of the 7 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for SCCG, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Apr 2026 | $24.41M | +258.0% | +13.6% | 2491.1% | |
| LTM Mar 2026 | $22.29K | +2824.7% | — | 0.2% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding SCCG) | $0 | +1541.3% | +13.6% | 0.0% | |
Competitors are the stored peer set for SCCG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 30.42M | 55.24M | 64.75M | 35.53M | 48.07M |
| Cost of Revenue | 167.05K | 212.83K | 532K | 744K | 28.67M |
| Gross Profit | 30.26M | 55.03M | 64.22M | 34.78M | 19.4M |
| Gross Margin | 99.5% | 99.6% | 99.2% | 97.9% | 40.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 0 | 0 | 0 | 0 | 14.14M |
| Operating Expenses | 5.63M | 11.71M | 18.25M | 46.5M | 13.1M |
| Depreciation & Amortization | 83.53K | 106.41K | 266K | 372K | 2.73M |
| EBITDA | 23.82M | 42.56M | 45.36M | (11.4M) | 9.04M |
| EBITDA Margin | 78.3% | 77.1% | 70.0% | -32.1% | 18.8% |
| Operating Income | 24.63M | 43.32M | 45.97M | (11.72M) | 6.31M |
| Operating Margin | 80.9% | 78.4% | 71.0% | -33.0% | 13.1% |
| Interest Income | 23.52M | 44.95M | 52.79M | 48.39M | 11.67M |
| Interest Expense | 10.42M | 21.55M | 29.19M | 27.8M | 0 |
| Other Income / Expenses | (11.31M) | (22.41M) | (30.07M) | (27.85M) | 0 |
| Income Before Tax | 13.32M | 20.91M | 15.9M | (39.57M) | 6.31M |
| Pre-Tax Margin | 43.8% | 37.9% | 24.6% | -111.4% | 13.1% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | 13.32M | 20.91M | 15.9M | (39.57M) | 6.31M |
| Net Margin | 43.8% | 37.9% | 24.6% | -111.4% | 13.1% |
| EPS (Basic) | 0.44 | 0.46 | 0.27 | (0.93) | 0.04 |
| EPS (Diluted) | 0.44 | 0.46 | 0.27 | (0.93) | 0.04 |
| Weighted Avg Shares | 26.32M | 37.74M | 44.24M | 47.41M | 46.9M |
| Weighted Avg Shares (Diluted) | 26.32M | 37.75M | 44.24M | 47.41M | 46.9M |
Sachem Capital Corp. 8.00% Note
AMEX:SCCG
Intrinsic Alpha fair value
Locked
Current Price
$24.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.